INCREASED MICROSOMAL IRREVERSIBLE BINDING OF PHENYTOIN BY VALPROIC ACID

被引：0
|
作者：
WANG, SL
LAI, ML
HUANG, JD
机构：
[1] NATL CHENG KUNG UNIV,COLL MED,DEPT PHARMACOL,TAINAN 70101,TAIWAN
[2] NATL CHENG KUNG UNIV,COLL MED,DEPT NEUROL,TAINAN 70101,TAIWAN
来源：
BIOCHEMICAL PHARMACOLOGY | 1991年 / 42卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1143 / 1144
页数：2
相关论文
共 50 条
  • [1] EFFECT OF VALPROIC ACID ON PHENYTOIN SERUM BINDING
    KRALL, R
    WARDELL, W
    GRINGERI, A
    NEUROLOGY, 1979, 29 (04) : 559 - 559
  • [2] VALPROIC ACID AND PHENYTOIN - PLASMA-PROTEIN BINDING
    CRAMER, JA
    MATTSON, RH
    NEUROLOGY, 1979, 29 (04) : 601 - 602
  • [3] EFFECT OF PHENYTOIN ON PROTEIN-BINDING OF VALPROIC ACID
    BRUNI, J
    GALLO, JM
    WILDER, BJ
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1979, 6 (04) : 453 - 454
  • [4] VALPROIC ACID PHENYTOIN INTERACTION
    FRIEL, PN
    LEAL, KW
    WILENSKY, AJ
    THERAPEUTIC DRUG MONITORING, 1979, 1 (02) : 243 - 248
  • [5] INTERACTIONS OF VALPROIC ACID WITH PHENYTOIN
    BRUNI, J
    GALLO, JM
    LEE, CS
    PERCHALSKI, RJ
    WILDER, BJ
    NEUROLOGY, 1980, 30 (11) : 1233 - 1236
  • [6] VALPROIC ACID - INVITRO PLASMA-PROTEIN BINDING AND INTERACTION WITH PHENYTOIN
    CRAMER, JA
    MATTSON, RH
    THERAPEUTIC DRUG MONITORING, 1979, 1 (01) : 105 - 116
  • [7] DECREASED PLASMA-PROTEIN BINDING OF PHENYTOIN IN PATIENTS ON VALPROIC ACID
    DAHLQVIST, R
    BORGA, O
    RANE, A
    WALSH, Z
    SJOQVIST, F
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 8 (06) : 547 - 552
  • [8] An Increased Cephalic Index: A Fetal Effect of Valproic Acid, but Not Phenytoin, Phenobarbital, or Carbamazepine
    Holmes, L. B.
    Hunt, A-T
    Stadelmaier, R.
    Deutsch, C.
    Adams, J.
    BIRTH DEFECTS RESEARCH, 2018, 110 (09): : 766 - 766
  • [9] INTERACTION BETWEEN VALPROIC ACID AND PHENYTOIN
    CLOSSON, RG
    WESTERN JOURNAL OF MEDICINE, 1983, 138 (01): : 108 - 108
  • [10] VALPROIC ACID - INTERACTIONS WITH PHENYTOIN AND PHENOBARBITAL
    KEYS, PA
    DRUG INTELLIGENCE & CLINICAL PHARMACY, 1982, 16 (10): : 737 - 739
12345